Rapilif-D 8/0.5 Capsule Combipack Substitute

Rapilif-D 8/0.5 Capsule Combipack is a combination of two drugs, namely; Silodosin and Dutasteride used to treat the symptoms of benign prostatic hyperplasia (BPH) in adults with an enlarged prostate gland. Silodosin belongs to a class of alpha-1 receptors (located in prostate and bladder) blocker that works by blocking the action of alpha-1 receptors and causes smooth muscle relaxation in the bladder and prostate. Dutasteride belongs to a class of 5-alpha reductase that works by blocking the action of a 5-alpha reductase enzyme, resulting in a shrink of the size of the prostate gland. Rapilif-D 8/0.5 Capsule Combipack reduces the BPH symptoms and improves your ability to urinate.

No, Rapilif-D 8/0.5 Capsule Combipack should not be taken along with blood-pressure-lowering medicines. Rapilif-D 8/0.5 Capsule Combipack may cause a sudden drop in your blood pressure which could lead to dizziness or fainting. Therefore, if Rapilif-D 8/0.5 Capsule Combipack is taken along with blood pressure lowering medicines, it could lead to a severe decrease in blood pressure which could be lethal.

Yes, Rapilif-D 8/0.5 Capsule Combipack may cause dizziness. You are advised not to drive or operate heavy machinery after taking Rapilif-D 8/0.5 Capsule Combipack as it may cause dizziness. Drive or operate machinery only if you are alert.

No, Rapilif-D 8/0.5 Capsule Combipack should not be taken by women. It is intended to treat symptoms of benign prostatic hyperplasia (BPH) in adult men only.

No, you are advised not to consume alcohol while taking Rapilif-D 8/0.5 Capsule Combipack as it makes you pee more and can irritate your bladder and also increase dizziness and lower blood pressure. Therefore, you are advised not to consume excessive amounts of alcohol while taking Rapilif-D 8/0.5 Capsule Combipack.